Interactions of tumor cells with dendritic cells: balancing immunity and tolerance - Wikidata - awgldk - TriplyDB

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

http://www.wikidata.org/entity/Q36975749

about

Pharmacologically directed cell disposal: labeling damaged cells for phagocytosis as a strategy against acute pancreatitis Cancer immunotherapy via dendritic cells Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.Ovarian cancer immunotherapy: opportunities, progresses and challenges Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling.Epigenetic Strategies to Boost Cancer Immunotherapies.The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice.Tumor antigen cross-presentation and the dendritic cell: where it all begins?Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Gene-carried chitosan-linked polyethylenimine induced high gene transfection efficiency on dendritic cells.Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies.Role of chaperones and FcgammaR in immunogenic death.Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?The effects of zoledronate on monocyte-derived dendritic cells from melanoma patients differ depending on the clinical stage of the disease Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.Oncogenic Transformation of Dendritic Cells and Their Precursors Leads to Rapid Cancer Development in Mice.Uric acid enhances the antitumor immunity of dendritic cell-based vaccine Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity.Monoclonal antibodies for cancer immunotherapy.Dendritic cells: a critical player in cancer therapy?Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Classification of chemotherapeutic agents based on their differential in vitro effects on dendritic cells.Dendritic cell-based immunotherapy for myeloid leukemias.The polarization of immune cells in the tumour environment by TGFbeta.microRNA-155 deficiency impairs dendritic cell function in breast cancer.Investigations of the functional states of dendritic cells under different conditioned microenvironments by Fourier transformed infrared spectroscopy.Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.Unravelling the complexity of cancer-immune system interplay.Dendritic cell-based immunotherapy in mesothelioma.The immune escape in melanoma: role of the impaired dendritic cell function.Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation

P2860

Q28396595-29A8A9B6-F334-43CA-8D04-75BB2F19EB80 Q29615444-D94A14F3-D50E-43A9-868A-FB15B0DE7087 Q30434822-6AF732BB-544B-403D-A34F-47AA082BC713 Q33584637-05780E3C-3572-4A1E-AF88-13004A71584F Q33702218-98DF5D05-D9B3-472F-8342-C60B990A2249 Q33744578-960CDA2E-F4C2-42DA-A90F-3E2453AC7B8B Q33838340-6F1939E8-52A0-49C4-AB7F-4578A9503F7E Q33842422-CDED7370-E713-424D-8A24-B6B5618D011E Q34210664-F4E9BF4B-1CA3-44D0-9E65-5F28FF706C50 Q34443707-D36B8B49-F9BC-464B-AB3A-FB2EA627528D Q34668764-72070570-82A7-46D6-9D0A-D9A7DB926393 Q34765867-33839241-4F37-4ACE-A963-2577A404D7AE Q35043529-DDC6E0D3-909C-437B-8489-E7A0A6C586EF Q35107009-DF9D8FC3-EBB6-436A-9DF6-55F7F24822AF Q35575030-4252EE62-9D3D-44EA-98BF-2943BC92CA79 Q35584599-8586D3F8-9F75-4B13-B336-DE286844BBA9 Q35886565-CD653858-1A38-4AFA-AB5B-D25633068804 Q36038020-C5A46F76-B2B6-4121-AC29-80B4A42A532A Q36117230-518152BC-1FA9-4E8B-B68A-4A4A5F4A649F Q36255342-75AF2FF0-54F7-4E34-8D69-76A17AEFAF91 Q36265772-8747FC8A-3294-4C1E-A6D9-83D79480E100 Q36373352-4D4823DA-7438-4CB3-ABAD-BD6E2F92D5A3 Q36453386-5A18612D-0E9B-43AB-B607-4EE032712844 Q36922033-CA89DEE2-960C-44FC-92D6-AD7E3DA00FD9 Q37181031-24748CB6-0614-4DF3-B806-50968EF872C6 Q37276138-DE4B44A2-54AD-49F0-889A-91B40FF532AD Q37291308-AA66FD2B-5838-469C-8B3E-FF364DA504AE Q37396070-11FDE554-EBAA-4B15-AC96-4146AB3F1266 Q37403295-5740D60C-D9B8-489F-A10C-4BEE06208CFC Q37420778-EEB97A81-13E1-4D14-BDA1-2F6C8B31936C Q37454364-2D0054E7-686B-4C6E-AC92-1E92FCF08806 Q37477262-90F43818-2FC5-4F93-B76B-84E6D04991C4 Q37501316-BDFC8FF6-ABDD-46AA-A210-C3D6E216B2C6 Q37619948-A4854112-9A35-49FC-8AFD-5ADF31930893 Q37765590-F666CFC7-5B07-41F7-A8BB-E31D8B3FE4FD Q38059514-039CC4AC-6C70-4B00-9EA5-DC65C2B6FBCC Q38250071-E1FF53DE-CD09-40EC-A253-38C5F90FDCB6 Q38288055-611EC3C7-CC7C-4BE9-AA9C-6C609F194F04 Q38867762-EA22A7E8-A88E-4DA2-8A70-BB886E3EDD5E Q39808301-21945431-C4D8-46B9-A5DF-D7B1CE5A14AE

P2860

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

http://www.wikidata.org/entity/Q36975749

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

@en

type

label

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

@en

prefLabel

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

@en

P1433

Q36975749-7212630C-ECE6-472B-8E36-40BB09D885B7

P1476

Q36975749-A7A2A396-A8CF-4BEC-A788-FFA79A09337B

P2093

Q36975749-CA480D03-3B82-495B-B6A9-9D4446B16BCA

Q36975749-F5365797-C935-4EFC-BCAC-B65B374F9E2E

Q36975749-FFBD1986-98DA-442C-82C2-82CDCB6094D3

P2860

Q36975749-02B22CDA-3BE1-4634-BE37-6F9215CF28C4

Q36975749-037882E7-78C5-4733-BC4E-6266320AFC0A

Q36975749-0717958E-DB47-47C3-86C0-3A4CC3FC3199

Q36975749-083BBF53-7F32-4F11-A8AB-39B92D30DE46

Q36975749-0875B780-CEB2-4BCA-913D-F0A6F73D93B6

Q36975749-09DE27AB-D2F3-4284-AD5A-64391CE2DE45

Q36975749-0A17BB5F-F502-4570-AD3C-793D690369AD

Q36975749-0CA3122C-575F-4FD4-B750-8E2FF36E263B

Q36975749-0E242586-7237-4455-B63C-B35226FC2775

Q36975749-144682A2-DAFD-474F-A414-0DBF0FDDBE1C

P2888

Q36975749-5C43D572-CE23-4049-B898-D11F8170ED8C

P304

Q36975749-1F7BBA33-D03C-40FA-936D-0C6D1E1C51DB

P31

Q36975749-8D652CE8-1C0E-4A57-BCAF-5550DB8C93A9

P356

Q36975749-0FA5B8EB-9E9E-4C9F-A3EE-8253636A4226

P433

Q36975749-91697F57-663B-4ADE-B695-271505BEE6C3

P478

Q36975749-830B9BED-29AD-4E4D-8098-018C266FBA97

P577

Q36975749-4FCDB754-948A-4060-8815-2EDC527CB01D

P5875

Q36975749-829DDC04-1D1B-4624-9A44-67CEC17BB0F0

P6179

Q36975749-FC04CA06-5B55-42BD-A1C9-C70FD1383EAC

P698

Q36975749-200057D3-0982-43E4-B127-5837C65C2877

P932

Q36975749-AAC7F7FF-0986-4C60-87AD-1644F617E258

P356

P1433

Cell Death & Differentiation

P1476

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance

@en

P2093

A K Palucka

http://www.w3.org/2001/XMLSchema#string

K M Dhodapkar

http://www.w3.org/2001/XMLSchema#string

M V Dhodapkar

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states

Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells

Dendritic cells and the control of immunity

Gout-associated uric acid crystals activate the NALP3 inflammasome

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Putting tumours in context

Identification of a factor that links apoptotic cells to phagocytes

Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway

P2888

P304

39-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CDD.4402247

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5897693

http://www.w3.org/2001/XMLSchema#string

P6179

1004009322

http://www.w3.org/2001/XMLSchema#string

P698

17948027

http://www.w3.org/2001/XMLSchema#string

P932

2762352

http://www.w3.org/2001/XMLSchema#string